E2 ModeratePreliminaryPEM not requiredObservationalPeer-reviewedMachine draft
Subclinical Sjögren's syndrome and anti-Ro/SSA-positive autoimmune fatigue syndrome in children.
Itoh, Y, Imai, T, Fujino, O et al. · Modern rheumatology · 2002 · DOI
Quick Summary
This study looked at children with severe fatigue and found that some had a specific antibody (anti-Ro/SSA) in their blood that is also found in Sjögren's syndrome, an autoimmune condition affecting moisture-producing glands. Eight children with fatigue syndrome tested positive for this antibody, and two of them showed actual gland damage on biopsy similar to Sjögren's syndrome, suggesting that some fatigue cases may actually be caused by an autoimmune condition affecting the glands.
Why It Matters
This research is relevant to ME/CFS because it identifies an autoimmune subset of patients with chronic fatigue who may have specific immunological markers (anti-Ro/SSA) and underlying glandular pathology. Understanding whether ME/CFS patients might similarly harbor undiagnosed autoimmune conditions could open new diagnostic and therapeutic avenues, particularly in pediatric populations.
Observed Findings
- 8 out of 122 AIFS patients (6.6%) tested positive for anti-Ro/SSA antibodies, predominantly female (7 of 8)
- All 8 anti-Ro/SSA-positive patients experienced fatigue and low-grade fever but had no dry mouth symptoms
- 7 of the 8 anti-Ro/SSA-positive patients showed reactivity to Ro52 on Western blot
- 2 of the 8 anti-Ro/SSA-positive patients had histories of recurrent parotitis and biopsy-confirmed subclinical Sjögren's syndrome
- 6 of the 8 anti-Ro/SSA-positive patients showed normal salivary gland histology on lip biopsy
Inferred Conclusions
- Anti-Ro/SSA-positive antibodies are detected in a subset of pediatric autoimmune fatigue syndrome patients
- Some anti-Ro/SSA-positive AIFS patients meet histopathological criteria for subclinical Sjögren's syndrome despite lacking typical dry mouth symptoms
- Autoimmune fatigue syndrome may represent a heterogeneous group including cases with underlying Sjögren's syndrome-like pathology
Remaining Questions
- What is the prevalence of anti-Ro/SSA positivity in ME/CFS populations, and does it differ by age or demographics?
- What is the long-term clinical course and outcomes in anti-Ro/SSA-positive AIFS patients compared to seronegative fatigue patients?
What This Study Does Not Prove
This study does not establish that anti-Ro/SSA positivity causes fatigue, nor does it prove that all autoimmune fatigue syndrome cases are Sjögren's syndrome. The cross-sectional design cannot establish temporal relationships or causality. The study cannot determine whether anti-Ro/SSA is present in typical ME/CFS populations or whether similar mechanisms operate in adult ME/CFS.
Tags
Symptom:Fatigue
Biomarker:Autoantibodies
Phenotype:Pediatric
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- DOI
- 10.3109/s101650200035
- PMID
- 24387058
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →